Comparison of biomarkers of exposure among US adult smokers, users of electronic nicotine delivery systems, dual users and nonusers, 2018-2019.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
holt (2023)
Sleep deprivation and adolescent susceptibility to vaping in the United States.
Population Clinical
Consumer Use
Reasons For Use
holtz (2022)
Sleep troubles in adolescence relate to future initiation of ENDS USE: a longitudinal cohort design using the PaTh study waves 4.5-5 (2017-2019).
Population Clinical
Consumer Use
Reasons For Use
holtz (2022)
Repeated nicotine vapor inhalation induces behavioral sensitization in male and female C57BL/6 mice.
Nonclinical
Safety Effects In Animals
honeycutt (2020)
a systematic review of the effects of e-cigarette use on lung function.
Population Clinical
Population Health Impact
honeycutt (2022)
Electronic Cigarette Use and Oral human Papillomavirus Infection among US adult Population: analysis of 2013-2016 NhaNES.
Individual Clinical
Safety
Adverse Effects
hong (2021)
Effects of Device Settings and E-Liquid Characteristics on Mouth-Throat Losses of Nicotine Delivered with Electronic Nicotine Delivery Systems (ENDS).
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
hosseini (2023)
Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status australian population: a study protocol for a randomized controlled trial.
Population Clinical
Cessation
Tobacco
howard (2022)
Nicotine pouch product awareness, interest and ever use among US adults who smoke, 2021
Individual Clinical
User Topography
Hrywna (2023)